{"title":"预后营养指数对肺癌放化疗疗效的影响","authors":"H. Demir, I. Beypınar, M. Baykara","doi":"10.37047/jos.2020-75476","DOIUrl":null,"url":null,"abstract":"Nearly one-fourth of the patients with NSCLC are diagnosed with locally advanced stage (stage III) and have a poor prognosis.4 For this condition, two treatment choices may be offered, induction chemotherapy followed by surgery or concurrent chemoradiation therapy.5,6 Nevertheless, even with advanced surgical techniques and postoperative consolidation chemotherapies, the local recurrence rates are 20-40%.7","PeriodicalId":31838,"journal":{"name":"Journal of Oncological Sciences","volume":"6 1","pages":"96-102"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Effect of the Prognostic Nutritional Index on Chemoradiotherapy Response in Lung Cancer\",\"authors\":\"H. Demir, I. Beypınar, M. Baykara\",\"doi\":\"10.37047/jos.2020-75476\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Nearly one-fourth of the patients with NSCLC are diagnosed with locally advanced stage (stage III) and have a poor prognosis.4 For this condition, two treatment choices may be offered, induction chemotherapy followed by surgery or concurrent chemoradiation therapy.5,6 Nevertheless, even with advanced surgical techniques and postoperative consolidation chemotherapies, the local recurrence rates are 20-40%.7\",\"PeriodicalId\":31838,\"journal\":{\"name\":\"Journal of Oncological Sciences\",\"volume\":\"6 1\",\"pages\":\"96-102\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Oncological Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.37047/jos.2020-75476\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Oncological Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37047/jos.2020-75476","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
The Effect of the Prognostic Nutritional Index on Chemoradiotherapy Response in Lung Cancer
Nearly one-fourth of the patients with NSCLC are diagnosed with locally advanced stage (stage III) and have a poor prognosis.4 For this condition, two treatment choices may be offered, induction chemotherapy followed by surgery or concurrent chemoradiation therapy.5,6 Nevertheless, even with advanced surgical techniques and postoperative consolidation chemotherapies, the local recurrence rates are 20-40%.7